Lifecore Biomedical Stock Price on December 2, 2024
| LFCR Stock | 7.71 0.43 5.91% |
Below is the normalized historical share price chart for Lifecore Biomedical extending back to February 15, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lifecore Biomedical stands at 7.71, as last reported on the 11th of December 2024, with the highest price reaching 7.71 and the lowest price hitting 7.28 during the day.
If you're considering investing in Lifecore Stock, it is important to understand the factors that can impact its price. Lifecore Biomedical appears to be slightly risky, given 3 months investment horizon. Lifecore Biomedical has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. By analyzing Lifecore Biomedical's technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please exercise Lifecore Biomedical's Downside Deviation of 4.26, risk adjusted performance of 0.1329, and Mean Deviation of 3.1 to check out if our risk estimates are consistent with your expectations.
As of 12/11/2024, Stock Based Compensation is likely to grow to about 6.5 M, while Total Stockholder Equity is likely to drop slightly above 51.2 M. . As of 12/11/2024, Price Earnings To Growth Ratio is likely to grow to 0.28, while Price To Sales Ratio is likely to drop 0.21. Lifecore Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of February 1996 | 200 Day MA 5.8797 | 50 Day MA 6.0116 | Beta 0.939 |
Lifecore |
Sharpe Ratio = 0.1575
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LFCR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.3 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.68 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Lifecore Biomedical is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lifecore Biomedical by adding it to a well-diversified portfolio.
Price Book 15.3467 | Enterprise Value Ebitda 11.6073 | Price Sales 2.0543 | Shares Float 18.4 M | Wall Street Target Price 8 |
Related Headline
Catalent Headline on 2nd of December 2024
Caisse DE Depot ET Placement DU Quebec Buys New Shares in Ca... by thelincolnianonline.com
Caisse DE Depot ET Placement DU Quebec purchased a new stake in shares of Catalent, Inc. during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The fund purchased 645,243 shares of the companys stock, valued at approximately ,082,000. Several other large investors
Lifecore Biomedical Valuation on December 2, 2024
It is possible to determine the worth of Lifecore Biomedical on a given historical date. On December 2, 2024 Lifecore was worth 7.54 at the beginning of the trading date compared to the closed value of 7.63. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lifecore Biomedical stock. Still, in general, we apply an absolute valuation method to find Lifecore Biomedical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lifecore Biomedical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lifecore Biomedical's related companies.
| Open | High | Low | Close | Volume | |
| 7.53 | 7.54 | 7.41 | 7.41 | 56,601 | |
12/02/2024 | 7.54 | 7.68 | 7.44 | 7.63 | 107,610 |
| 7.64 | 7.64 | 7.35 | 7.47 | 91,295 |
| Backtest Lifecore Biomedical | | | Lifecore Biomedical History | | | Lifecore Biomedical Valuation | Previous | Next |
Lifecore Biomedical Trading Date Momentum on December 2, 2024
| On December 03 2024 Lifecore Biomedical was traded for 7.47 at the closing time. The top price for the day was 7.64 and the lowest listed price was 7.35 . The trading volume for the day was 91.3 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.10% . The trading delta at closing time against the current closing price is 4.59% . |
Lifecore Biomedical Fundamentals Correlations and Trends
By evaluating Lifecore Biomedical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lifecore financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lifecore Biomedical Stock history
Lifecore Biomedical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lifecore is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lifecore Biomedical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lifecore Biomedical stock prices may prove useful in developing a viable investing in Lifecore Biomedical
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 36.7 M | 26.4 M | |
| Net Loss | -92 M | -87.4 M |
Lifecore Biomedical Stock Technical Analysis
Lifecore Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lifecore Biomedical Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Lifecore Biomedical cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lifecore Biomedical December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Lifecore Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lifecore Biomedical shares will generate the highest return on investment. By undertsting and applying Lifecore Biomedical stock market strength indicators, traders can identify Lifecore Biomedical entry and exit signals to maximize returns
Lifecore Biomedical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lifecore Biomedical's price direction in advance. Along with the technical and fundamental analysis of Lifecore Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lifecore to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1329 | |||
| Jensen Alpha | 0.559 | |||
| Total Risk Alpha | 0.0504 | |||
| Sortino Ratio | 0.1439 | |||
| Treynor Ratio | 0.4926 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.